Mucins in cancer: protection and control of the cell surface

@article{Hollingsworth2004MucinsIC,
  title={Mucins in cancer: protection and control of the cell surface},
  author={Michael A. Hollingsworth and Benjamin J. Swanson},
  journal={Nature Reviews Cancer},
  year={2004},
  volume={4},
  pages={45-60}
}
Mucins — large extracellular proteins that are heavily glycosylated with complex oligosaccharides — establish a selective molecular barrier at the epithelial surface and engage in morphogenetic signal transduction. Alterations in mucin expression or glycosylation accompany the development of cancer and influence cellular growth, differentiation, transformation, adhesion, invasion and immune surveillance. Mucins are used as diagnostic markers in cancer, and are under investigation as therapeutic… 
Structure and function of the cell surface (tethered) mucins.
TLDR
This review focuses on the three best-characterized cell surface mucins expressed in the respiratory tract: MUC1, MUC4, and MUC16.
Transmembrane mucins as novel therapeutic targets
TLDR
Rises in the normally low levels of mucin fragments in serum have been used as markers of disease, such as tumor burden, for many years and several approaches are being examined that target mucins for immunization or nanomedicine using mucin-specific antibodies.
MUCINS: POTENTIAL FOR OVARIAN CANCER BIOMARKERS
TLDR
The role of mucin as potential biomarker for the ovarian cancer is focuses on the importance of mucins in the pathogenesis of a number of cancers.
Mucin1 and Mucin16: Therapeutic Targets for Cancer Therapy
TLDR
The biological roles of the transmembrane mucins M UC1 and MUC16 in the context of hallmarks of cancer and current efforts to develop MUC1- and M UC16-targeted therapies are discussed.
Glycans in Cancer
TLDR
This chapter gives an overview on cancer-specific changes of glycosylation on O- and N-glycans, with the focus on the function of these oligosaccharides in cancer progression.
Tumour Immunomodulation: Mucins in Resistance to Initiation and Maturation of Immune Response Against Tumours
TLDR
Although mucins provide molecular targets for immune system's tumour recognition, their characteristics dictate that the nature of immune response required for recognition and lyses of mucin‐expressing tumours needs to follow predominantly a MHC‐unrestricted αβ TCR‐mediated effector cell response.
Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer
TLDR
An overview of the current knowledge of the functions of transmembrane mucins in inflammatory processes and carcinogenesis is presented in order to better understand the diverse functions of these multifunctional proteins.
...
...

References

SHOWING 1-10 OF 219 REFERENCES
Intestinal mucins in health and disease.
TLDR
Recent advances in understanding of mucin structure, secretion and functional properties are reviewed and implications for diseases such as cystic fibrosis, peptic ulcer, malignancy and inflammatory bowel disease are briefly discussed.
Identification of MUC1 proteolytic cleavage sites in vivo.
TLDR
The MUC1 proteolytic cleavage site shows homology with sequences in other cell-surface-associated proteins and may represent a common mechanism for processing of these molecules.
Multiple facets of sialomucin complex/MUC4, a membrane mucin and erbb2 ligand, in tumors and tissues (Y2K update).
TLDR
Results suggest that SMC has multiple functions in epithelia and is tightly regulated in those tissues where its special functions are required, including the mammary gland and uterine luminal epithelium.
MUC17, a novel membrane-tethered mucin.
TLDR
This novel mucin, designated MUC17, contains an extended, repetitive extracellular glycosylation domain and a carboxyl terminus with two EGF-like domains, a SEA module domain, a transmembrane domain, and a cytoplasmic domain with potential serine and tyrosine phosphorylation sites.
Colorectal Cancer in Mice Genetically Deficient in the Mucin Muc2
TLDR
Muc2 is involved in the suppression of colorectal cancer and frequently developed adenomas in the small intestine that progressed to invasive adenocarcinoma, as well as rectal tumors.
Delayed Mammary Tumor Progression in Muc-1 Null Mice (*)
TLDR
Mice deficient in Muc-1 were generated using homologous recombination in embryonic stem cells and the growth rate of primary breast tumors induced by polyoma middle T antigen was found to be significantly slower in Muca-1 deficient mice, suggesting that MUC-1 plays an important role in the progression of mammary carcinoma.
Overexpression of sialomucin complex, a rat homologue of MUC4, inhibits tumor killing by lymphokine-activated killer cells.
TLDR
It is demonstrated that overexpression ofSMC masks the surface antigens on target tumor cells and effectively suppresses tumor cell killing by cytotoxic lymphocytes, providing an explanation for the proposed role of SMC/MUC4 in tumor progression.
Oligosaccharides Expressed on MUC1 Produced by Pancreatic and Colon Tumor Cell Lines*
TLDR
An epitope-tagged form of MUC1 was developed that allowed the detection of multiple M UC1 glycoforms and established the presence of a number of important blood group and tumor-associated carbohydrate antigens on MUC 1 expressed by two pancreatic tumor cell lines and two colon tumor cell Lines.
Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components
TLDR
There is a delicate balance between adhesion and anti- adhesion forces in episialin expressing cells, which can be shifted towards adhesion by strengthening the integrin-mediated adhesion, or towards anti-adhesion by increasing the level of expression of episIALin.
...
...